Alyeska Investment Group
LLY icon

Alyeska Investment Group’s Eli Lilly LLY Stock Holding History

Alyeska Investment Group’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-522
Closed -$561K – 692
2025
Q4 		$561K Buy
+522
New +$499K ﹤0.01% 556
2025
Q2 		– Sell
-3,055
Closed -$2.52M – 625
2025
Q1 		$2.52M Buy
+3,055
New +$2.54M 0.01% 407
2024
Q3 		– Sell
-82,078
Closed -$74.3M – 626
2024
Q2 		$74.3M Sell
82,078
-78,266
-49% -$62.6M 0.42% 76
2024
Q1 		$125M Sell
160,344
-30,738
-16% -$21.9M 0.77% 28
2023
Q4 		$111M Buy
191,082
+34,243
+22% +$20M 0.74% 29
2023
Q3 		$84.2M Buy
+156,839
New +$80.8M 0.57% 48
2022
Q4 		– Sell
-261,724
Closed -$84.6M – 468
2022
Q3 		$84.6M Buy
+261,724
New +$82.9M 0.99% 14
2022
Q1 		– Sell
-3,077
Closed -$850K – 629
2021
Q4 		$850K Sell
3,077
-215,222
-99% -$54.6M 0.01% 543
2021
Q3 		$50.4M Buy
218,299
+60,362
+38% +$14.9M 0.62% 32
2021
Q2 		$36.3M Sell
157,937
-207
-0.1% -$41.6K 0.42% 66
2021
Q1 		$29.5M Sell
158,144
-75,983
-32% -$14.9M 0.38% 71
2020
Q4 		$39.5M Buy
234,127
+21,901
+10% +$3.27M 0.56% 45
2020
Q3 		$31.4M Buy
+212,226
New +$32.8M 0.48% 56
2017
Q2 		– Sell
-1,580,087
Closed -$133M – 510
2017
Q1 		$133M Buy
1,580,087
+272,923
+21% +$21.9M 1.08% 9
2016
Q4 		$96.1M Buy
1,307,164
+844,505
+183% +$62.9M 0.8% 19
2016
Q3 		$37.1M Buy
+462,659
New +$37M 0.34% 94
2015
Q4 		– Sell
-39,604
Closed -$3.31M – 428
2015
Q3 		$3.31M Buy
+39,604
New +$3.34M 0.04% 294
2015
Q2 		– Sell
-601,652
Closed -$43.7M – 536
2015
Q1 		$43.7M Buy
601,652
+142,491
+31% +$10.1M 0.61% 28
2014
Q4 		$31.7M Sell
459,161
-16,444
-3% -$1.11M 0.54% 52
2014
Q3 		$30.8M Sell
475,605
-22,493
-5% -$1.42M 0.63% 34
2014
Q2 		$31M Buy
+498,098
New +$29.7M 0.69% 23

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Alyeska Investment Group's LLY Position: Q1 2026 in Review

Alyeska Investment Group sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 522 shares — an estimated $561K sold.

Alyeska Investment Group first reported a position in LLY in Q2 2014 and held it in 21 quarters. The position peaked at $133M in Q1 2017. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Alyeska Investment Group reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
  • Alyeska Investment Group sold 522 Eli Lilly shares in Q1 2026, an estimated $561K.
  • Alyeska Investment Group first reported a position in Eli Lilly in Q2 2014 and held it in 21 quarters.
  • Alyeska Investment Group's Eli Lilly position peaked at $133M in Q1 2017.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Alyeska Investment Group's 13F filing for Q1 2026, filed 15 May 2026.